Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vivo Bio Tech Ltd has submitted a compliance report to BSE regarding the re-lodgement of physical share transfer requests, as required under the SEBI circular dated July 2, 2025. The company confirmed it publicized the special window for re-lodging physical share transfer requests through newspaper advertisements in Financial Express (English) and Nava Telangana (Telugu) on July 15, 2025 and September 15, 2025. The Registrar and Share Transfer Agent, Aarthi Consultants Limited, reported that no transfer requests were received, processed, approved, or rejected during September 2025. The report is signed by the Company Secretary and the Compliance Officer of the Registrar.
This is a routine regulatory compliance filing with no material impact on shareholders or the stock price, as no transfer activity was recorded during the month.